Hexahydrocyclopentyl[f]indazole carboxamides and derivatives thereof as selective glucocorticoid receptor modulators

Details for Australian Patent Application No. 2009217493 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Dankulich, William P.; Meissner, Robert S.; Mitchell, Helen J.; McMaster, Danielle M.

Agent Spruson & Ferguson

Pub. Number AU-A-2009217493

PCT Pub. Number WO2009/108525

Priority 61/070,330 21.03.08 US; 61/067,129 26.02.08 US

Filing date 16 February 2009

Wipo publication date 3 September 2009

International Classifications

C07D 401/00 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/00 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/00 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

29 July 2010 PCT application entered the National Phase

  PCT publication WO2009/108525 Priority application(s): WO2009/108525

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009217494-Method for producing a crunchy food product

2009217492-Method of manufacturing a dual interface separable insulated connector with overmolded faraday cage